Antoni Ribas
InvestorVenture Partner at Ysios Capital
About
Antoni Ribas, M.D., Ph.D., is a physician-scientist and Professor of Medicine, Surgery, and Molecular and Medical Pharmacology at UCLA, where he directs the Tumor Immunology Program at the Jonsson Comprehensive Cancer Center and the Parker Institute for Cancer Immunotherapy Center. His research focuses on malignant melanoma, gene-engineered T cells, PD-1 blockade, and BRAF-targeted therapies, and he contributed to the clinical development of several FDA-approved drugs including pembrolizumab, vemurafenib, and dabrafenib. He currently serves as President of the American Association for Cancer Research and is an elected member of the U.S. National Academy of Medicine.
Invests in
Biotech
Colleagues at Ysios Capital
Almudena Méndez
Associate at Ysios Capital
Arturo Urrios
Partner at Ysios Capital
Carlos Garcia-Echeverria
Venture Partner at Ysios Capital
Carlos Paya
Venture Partner at Ysios Capital
Catalina Cuchy
Executive Assistant at Ysios Capital
Cristina Garmendia
General Partner at Ysios Capital
David L. Lacey
Venture Partner at Ysios Capital
Guillem Laporta
Partner at Ysios Capital